(TZOO) Travelzoo - Overview
Stock: Travel, Entertainment, Local Deals
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 61.4% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.92 |
| Alpha | -91.71 |
| Character TTM | |
|---|---|
| Beta | 1.173 |
| Beta Downside | 1.197 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.43% |
| CAGR/Max DD | 0.06 |
Description: TZOO Travelzoo January 19, 2026
Travelzoo (NASDAQ:TZOO) is an internet-media company that curates and sells travel, entertainment, and local-experience deals worldwide through its website, email newsletters, mobile apps, and a network of partner sites. The firm operates four reporting segments-Travelzoo North America, Travelzoo Europe, Jack’s Flight Club, and New Initiatives-each delivering deal-focused content to a membership base that purchases vouchers for hotels, spas, restaurants, and other services.
Its flagship Travelzoo platform distributes the “Top 20” email newsletters and standalone deal alerts, while Jack’s Flight Club runs a subscription model that alerts members to unusually low airfares. The Travelzoo Network syndicates the company’s curated offers to third-party websites, expanding reach without proportionate incremental cost.
As of FY 2023, Travelzoo reported $277 million in revenue, a 7 % YoY increase driven by higher average order values and a 12 % rise in paid-member subscriptions for Jack’s Flight Club. The business is sensitive to discretionary-spending trends and the broader online travel market, which is projected to grow at a 9 % CAGR through 2028 as consumers shift more bookings to digital channels. A key operational metric is the “deal conversion rate,” currently hovering around 3.5 %, indicating room for efficiency gains through better targeting and AI-driven personalization.
For a deeper quantitative assessment, you may find the ValueRay platform useful for digging into the latest financials and valuation multiples.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 7.94m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA -2.75 > 1.0 |
| NWC/Revenue: -12.70% < 20% (prev -8.34%; Δ -4.37% < -1%) |
| CFO/TA 0.26 > 3% & CFO 12.1m > Net Income 7.94m |
| Net Debt (-1.94m) to EBITDA (11.6m): -0.17 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.0m) vs 12m ago -3.33% < -2% |
| Gross Margin: 82.33% > 18% (prev 0.88%; Δ 8145 % > 0.5%) |
| Asset Turnover: 186.0% > 50% (prev 167.0%; Δ 19.02% > 0%) |
| Interest Coverage Ratio: -17.36 > 6 (EBITDA TTM 11.6m / Interest Expense TTM -645.0k) |
Altman Z'' 0.25
| A: -0.25 (Total Current Assets 24.4m - Total Current Liabilities 35.8m) / Total Assets 46.2m |
| B: 0.15 (Retained Earnings 6.92m / Total Assets 46.2m) |
| C: 0.23 (EBIT TTM 11.2m / Avg Total Assets 48.3m) |
| D: -0.16 (Book Value of Equity -8.10m / Total Liabilities 49.2m) |
| Altman-Z'' Score: 0.25 = B |
Beneish M -3.04
| DSRI: 0.89 (Receivables 12.5m/13.2m, Revenue 89.9m/84.4m) |
| GMI: 1.06 (GM 82.33% / 87.67%) |
| AQI: 1.11 (AQ_t 0.37 / AQ_t-1 0.33) |
| SGI: 1.07 (Revenue 89.9m / 84.4m) |
| TATA: -0.09 (NI 7.94m - CFO 12.1m) / TA 46.2m) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of TZOO shares?
Over the past week, the price has changed by -5.55%, over one month by -15.99%, over three months by -25.46% and over the past year by -75.99%.
Is TZOO a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TZOO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.3 | 295.9% |
| Analysts Target Price | 22.3 | 295.9% |
| ValueRay Target Price | 4.8 | -13.9% |
TZOO Fundamental Data Overview February 04, 2026
P/E Forward = 4.5086
P/S = 0.7266
P/B = 179.2638
P/EG = 1.1367
Revenue TTM = 89.9m USD
EBIT TTM = 11.2m USD
EBITDA TTM = 11.6m USD
Long Term Debt = 6.55m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.06m USD (from shortTermDebt, last quarter)
Debt = 6.55m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.94m USD (from netDebt column, last quarter)
Enterprise Value = 63.4m USD (65.3m + Debt 6.55m - CCE 8.49m)
Interest Coverage Ratio = -17.36 (Ebit TTM 11.2m / Interest Expense TTM -645.0k)
EV/FCF = 5.30x (Enterprise Value 63.4m / FCF TTM 12.0m)
FCF Yield = 18.85% (FCF TTM 12.0m / Enterprise Value 63.4m)
FCF Margin = 13.29% (FCF TTM 12.0m / Revenue TTM 89.9m)
Net Margin = 8.83% (Net Income TTM 7.94m / Revenue TTM 89.9m)
Gross Margin = 82.33% ((Revenue TTM 89.9m - Cost of Revenue TTM 15.9m) / Revenue TTM)
Gross Margin QoQ = 82.90% (prev 78.40%)
Tobins Q-Ratio = 1.37 (Enterprise Value 63.4m / Total Assets 46.2m)
Interest Expense / Debt = 5.19% (Interest Expense 340.0k / Debt 6.55m)
Taxrate = 28.31% (5.40m / 19.1m)
NOPAT = 8.03m (EBIT 11.2m * (1 - 28.31%))
Current Ratio = 0.68 (Total Current Assets 24.4m / Total Current Liabilities 35.8m)
Debt / Equity = -0.81 (negative equity) (Debt 6.55m / totalStockholderEquity, last quarter -8.10m)
Debt / EBITDA = -0.17 (Net Debt -1.94m / EBITDA 11.6m)
Debt / FCF = -0.16 (Net Debt -1.94m / FCF TTM 12.0m)
Total Stockholder Equity = -5.42m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.42% (Net Income 7.94m / Total Assets 46.2m)
RoE = -146.5% (negative equity) (Net Income TTM 7.94m / Total Stockholder Equity -5.42m)
RoCE = 989.8% (EBIT 11.2m / Capital Employed (Equity -5.42m + L.T.Debt 6.55m))
RoIC = -148.1% (out of range, set to none) (NOPAT 8.03m / Invested Capital -5.42m)
WACC = 9.65% (E(65.3m)/V(71.9m) * Re(10.24%) + D(6.55m)/V(71.9m) * Rd(5.19%) * (1-Tc(0.28)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.34%
[DCF Debug] Terminal Value 67.34% ; FCFF base≈13.0m ; Y1≈10.1m ; Y5≈6.51m
Fair Price DCF = 8.69 (EV 93.1m - Net Debt -1.94m = Equity 95.1m / Shares 10.9m; r=9.65% [WACC]; 5y FCF grow -26.19% → 2.90% )
EPS Correlation: -10.57 | EPS CAGR: -46.91% | SUE: -1.61 | # QB: 0
Revenue Correlation: 79.15 | Revenue CAGR: 13.82% | SUE: -0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.31 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.29 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+147.0% | Growth Revenue=+17.0%